389 participants
Real World Outcomes Study of Hepatic Encephalopathy Patients' Experience on Rifaximin (PROSPER)
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2018-12-13
- Start Date:
- 2015-06-30
- Completion:
- 2018-09-29
Conditions
- Hepatic Encephalopathy
Interventions
- OTHER
No Results Yet